The Success of Medicare's End-Stage Renal-Disease Program
- 20 August 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (8), 434-438
- https://doi.org/10.1056/nejm198108203050805
Abstract
The 92d Congress extended Medicare benefits to patients with end-stage renal disease (ESRD), sparing patients the financial burden of treating this catastrophic illness. The costs of the ESRD program have been contained better than those of health care generally; payment was originally limited by a screen of $138 per dialysis but could be higher if higher cost was documented. About 48 per cent of patients receive dialysis in units outside hospitals. The majority of these units are operated for profit, in which physicians share. The payment to these facilities has remained constant while payment to the nonprofit hospitals' units has increased markedly.Keywords
This publication has 6 references indexed in Scilit:
- Indirect Costs of Federally Supported ResearchScience, 1981
- Implications for health care policy. A social and demographic profile of hemodialysis patients in the United StatesJAMA, 1981
- Competition and Cost ContainmentNew England Journal of Medicine, 1980
- The New Medical-Industrial ComplexNew England Journal of Medicine, 1980
- The Physician's Role in the Cost-Containment ProblemPublished by American Medical Association (AMA) ,1979
- The Internal Organization of Hospitals: Some Economic ImplicationsThe Bell Journal of Economics, 1977